Lucigenin (NSC-151912) (L-6868) is a chemiluminescent probe used to indicate the presence of endogenously generated superoxide anion radicals in cells.

Upon single-electron reduction of Lucigenin by a radical species the subsequent form of Lucigenin presents amplified chemiluminescence which is measurable and can be correlated to the respective amount of reactive radical species present in the system. In addition to indicating the presence of radicals in cells, Lucigenin shows interaction with redox-active oxidoreductase enzymes. Lucigenin is shown to mediate the reduction of cytochrome C by xanthine oxidase and to increase the rate of NADPH oxidation.

Instructions
1. Prepare Lucigenin Solution:
Dissolve Lucigenin in an appropriate solvent (e.g., PBS or HEPES buffer) at a concentration of 10–50 µM, which can be optimized based on experimental requirements.
The solution should be prepared and used immediately, and avoid long-term storage to prevent degradation.
2. Experimental Preparation:
Inoculate cells in a suitable culture dish or microplate (usually a 96-well plate).
Treat cells to induce the generation of superoxide anion radicals (e.g., by adding specific stimuli or drugs).
3. Add Lucigenin:
Add Lucigenin solution (1~10uM) to the cell culture system, ensuring that it is incubated with the stimuli. Usually incubate at 37°C for 10–60 minutes, which can be optimized based on the experiment.
4. Chemiluminescent Detection:
Use a chemiluminescent detection instrument (e.g., a microplate reader or a fluorometer) to measure the luminescent signal.
The intensity of chemiluminescence is proportional to the amount of superoxide anions produced.
5. Data analysis:
Compare the luminescence intensity of the experimental group with that of the control group to evaluate the level of superoxide anion production.
Antioxidants or enzymes (such as superoxide dismutase, SOD) can be combined for verification experiments.

The above information is based on published literature. Experimental procedures should be appropriately modified to meet specific research demands.

DMSO: 80 mg/mL (156.71 mM), Sonication is recommended.

10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (6.46 mM), Sonication is recommended.